Revenue Cycle Advisory for Ophthalmology.

Why Revenue Cycle Management Is Different for Ophthalmology

Ophthalmology and retina practices navigate dual medical vs. routine vision payer routing, bilateral diagnostic testing (OCT, visual fields, fundus photography, biometry), cataract/glaucoma/cornea surgery in ASCs, and high-cost anti-VEGF intravitreal injections.

Billing requires strict accuracy across 92002–92014 ophthalmological exams vs. 99202–99215 E/M codes, unilateral/bilateral diagnostic test rules, CPT 67028 intravitreal injections, J-code biologic/biosimilar drug units, JW/JZ wastage, and Global Surgery Modifiers 24, 25, 55, 58, 78, 79, LT/RT.

• Billing requires strict accuracy across 92002–92014 ophthalmological exams vs. 99202–99215 E/M codes, unilateral/bilateral diagnostic test rules, CPT 67028 intravitreal injections, J-code biologic/biosimilar drug units, JW/JZ wastage, and Global Surgery Modifiers 24, 25, 55, 58, 78, 79, LT/RT.
• Alignment with CMS National Correct Coding Initiative (NCCI) PTP edits, MUE unit caps, and regional MAC Local Coverage Determinations (LCDs)
• Pre-bill verification of prior authorization numbers, rendering provider credentials, and site-of-service differentials
• Contractual fee-schedule modeling to catch commercial and Medicare Advantage underpayments at 835ERA posting

Prior Authorization, Medical Necessity & Denial Patterns in Ophthalmology

Retina anti-VEGF step-therapy rules (requiring bevacizumab trial before aflibercept/faricimab), cataract visual-acuity LCD documentation, and blepharoplasty visual-field medical necessity require watertight pre-procedure verification.

High-value leakage occurs in anti-VEGF J-code/NDC unit or step-therapy denials, unbilled or improperly split post-operative cataract co-management (Modifiers 54/55), and NCCI bundling between OCT/fundus imaging and clinic exams.

• Front-end eligibility and benefit verification tied directly to scheduled CPT/HCPCS procedure codes and site-of-service POS indicators
• Automated tracking of payer-specific prior authorization validity windows, unit thresholds, and peer-to-peer clinical escalation timelines
• Root-cause categorization of CARC 50 (medical necessity), CARC 97 (bundling/inclusive service), CARC 197 (missing precertification), and CARC 4/16 (modifier/claim data errors)
• Contractual underpayment variance auditing against Medicare Physician Fee Schedule (MPFS), ASC payment rates, and commercial payer fee schedules

Important KPIs, Benchmarks & A/R Economics for Ophthalmology Groups

For ophthalmology organizations between $5M and $100M+ in net patient revenue, eliminating specialty coding friction, prior authorization write-offs, and silent payer underpayments directly improves cash velocity and operating EBITDA.

Aligning ophthalmic EHRs (Nextech, ModMed EMA, Integrity, Epic Kaleidoscope) with retina drug inventory logs and ASC surgical schedules protects both drug margins and global surgical compliance.

In-House vs. Outsourced Ophthalmology Billing: What to Evaluate in an RCM Partner

Deciding whether to run ophthalmology billing internally, operate a hybrid model, or outsource to a specialty RCM company requires looking past headline percentage fees. A billing vendor charging 4% that leaves 6% of net collectible revenue on the table through unappealed CARC 97/50 denials or unworked >90-day A/R costs far more than a disciplined internal or specialty-calibrated operation.

RCM Advisory Partners helps organizations benchmark their current operation before negotiating with vendors, and structures rigorous evaluation criteria when an external partner is warranted.

• Encounter-to-claim charge capture reconciliation across all ophthalmology service locations
• Specialty CPT, HCPCS, ICD-10-CM, and modifier accuracy audit for ophthalmology
• Prior authorization intake, medical-necessity documentation, and CARC 197/50 denial prevention
• Line-level payer allowable reconciliation and aged >90-day A/R recovery workflow review
• Verify certified coder proficiency in ophthalmology CPT/HCPCS hierarchies, NCCI bundling edits, and Medicare LCDs
• Audit true net collection yield against contracted ophthalmology fee schedules rather than blended gross adjustments
• Require transparent workqueue visibility on >60 and >90 day A/R and clinical appeal overturn rates

30/60/90-Day Ophthalmology Revenue Cycle Diagnostic & Optimization Plan

Our advisory engagements translate ophthalmology claim and remittance data into a prioritized 90-day execution roadmap:

1. 01
   Days 1–30: Specialty Claim Audit, Coding Review & Fee Schedule Reconciliation

   Audit a statistically valid sample of paid, denied, and zero-pay ophthalmology claims across top commercial and Medicare payers; benchmark CPT/modifier distribution and identify immediate underpayment and denial recovery opportunities.

2. 02
   Days 31–60: Prior Authorization, Scrubber Edit & EHR Template Remediation

   Reconfigure front-end authorization matrices, clinical documentation templates, and clearinghouse NCCI/LCD pre-bill edits to stop preventable denials before 837 submission.

3. 03
   Days 61–90: Aged A/R Recovery, Payer Escalation & Vendor SLA Governance

   Deploy structured appeal playbooks for high-value surgical, diagnostic, or infusion claims, and establish monthly KPI scorecards holding internal leads or external billing partners accountable.